Zobrazeno 1 - 4
of 4
pro vyhledávání: '"mRNA vaccination vulnerable population"'
Autor:
Frederik Novak, Anna Christine Nilsson, Emil Birch Christensen, Caroline Louise Stougaard, Mike Bogetofte Barnkob, Dorte K. Holm, Agnes Hauschultz Witt, Keld-Erik Byg, Isik S. Johansen, Christian Nielsen, Tobias Sejbaek
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThis study examines the humoral and cellular response in multiple sclerosis (MS) patients on anti-CD20 therapy before and after the 1st to 4th BNT162b2 mRNA SARS-CoV-2 vaccination and the relationship with breakthrough infection.MethodsPart
Externí odkaz:
https://doaj.org/article/4bf15d137f534304ac83518451328cd4
Autor:
Tianchen Zhao, Yuta Tani, Chieko Makino-Okamura, Morihito Takita, Chika Yamamoto, Eiki Kawahara, Toshiki Abe, Sota Sugiura, Hiroki Yoshimura, Taiga Uchiyama, Isato Yamazaki, Harumichi Ishigame, Takaharu Ueno, Kazu Okuma, Masatoshi Wakui, Hidehiro Fukuyama, Masaharu Tsubokura
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
This study investigates the neutralizing activity against the XBB1.5 variant and the ancestral strain in a population post-bivalent vaccination using a pseudo virus assay validated with authentic virus assay. While bivalent booster vaccination and pa
Externí odkaz:
https://doaj.org/article/0353279085f74420a99d71b4c5e96775
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Novak F; Department of Neurology, Hospital Southwest Jutland, University Hospital of Southern Denmark, Esbjerg, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark., Nilsson AC; Clinical Immunology Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Christensen EB; Clinical Immunology Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense, Denmark., Stougaard CL; Clinical Immunology Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense, Denmark., Barnkob MB; Clinical Immunology Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense, Denmark., Holm DK; Clinical Immunology Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark., Witt AH; Department of Neurology, Hospitalsenhed Midt, Viborg, Denmark., Byg KE; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense, Denmark.; Department of Rheumatology, Odense University Hospital, Odense, Denmark., Johansen IS; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark., Nielsen C; Clinical Immunology Research Unit, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense, Denmark., Sejbaek T; Department of Neurology, Hospital Southwest Jutland, University Hospital of Southern Denmark, Esbjerg, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Sep 05; Vol. 15, pp. 1432348. Date of Electronic Publication: 2024 Sep 05 (Print Publication: 2024).